Predictive value of interleukin 1 gene polymorphisms for surgery

Annals of the Rheumatic Diseases

Volumn 59, Issue 9, 2000, Pages 695-699

  Crilly, Anne ^a   Maiden, Nicola ^a   Capell, Hilary A ^a   Madhok, Rajan ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ADULT; AGED; ALLELISM; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HIP SURGERY; HUMAN; JOINT SURGERY; KNEE SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ALLELES; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RETROSPECTIVE STUDIES; SIALOGLYCOPROTEINS;

EID: 0033828428     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.9.695     Document Type: Article

References (29)

1. 1 Wolf F, Zwillich SH. The long term outcomes of rheumatoid arthritis. Arthritis Rheum 1998;41:1072-82.
2. 2 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
3. 3 Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA DR β1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
4. 4 Crilly, A, Maiden N, Capell HA, Madhok R. Genotyping for disease associated HLA DR β 1 alleles and the need for early joint surgery in rheumatoid arthritis: a quantitative evaluation. Ann Rheum Dis 1999;58:114-17.
5. 5 Feldmann M, Brennana FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
6. 6 Miossec P. Cytokines and the pathophysiology of bone erosions in rheumatoid arthritis. J Clin Rheumatol 1997;3: S81-3.
7. 7 Eastgate JA, Wood NC, DiGiovine FS, Symons JA, Grinlinton FM, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988;2:706-9.
8. 8 Mansfield JC, Holden H, Tarlow JK, DiGiovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin 1 receptor antagonist. Gastroenterology 1994;106:637-42.
9. 9 DiGiovine FS, Takhsh E, Blakemore AIF, Duff GW. Single base polymorphism at -511 in the human interleukin 1 β gene. Hum Mol Genet 1992;1:450.
10. 10 Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86bp tandem repeat. Hum Genet 1993;91: 403-4.
11. 11 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. 12 Bailly S, DiGiovine FS, Duff GW. Polymorphic tandem repeat region in interleukin 1 α intron 6. Hum Genet 1993; 91:85-6.
13. 13 Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taq I polymorphism in the human interleukin 1 β (IL-1 β) gene correlates with IL-1 β secretion in vitro. Eur J Clin Invest 1992;22:396-402.
14. 14 Berghoidt R, Karlsen AE, Johannesen J, Hansen PM, Dinarello CA, Nerup J, et al. Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promoter region (P2) and their relation to insulin dependent diabetes mellitus (IDDM). The Danish study group of diabetes in childhood. Cytokine 1995;7:727-33.
15. 15 Tarlow JK, Clay FE, Cork MJ, Blakemore AIF, McDonagh AJG, Messenger AG, et al. Severity of alopecia areata is associated with a porymorphism in the interleukin 1 receptor antagonist gene. J Invest Dermatol 1994;103:387-90
16. 16 Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin 1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994;37:1380-5.
17. 17 Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 1998;87:309-13.
18. 18 Tountas NA, Casini-Raggi V, Yang H, DiGiovine FS, Vecchi M, Kam L, et al. Functional and ethnic association of allele 2 of the interleukin 1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999;117:806-13.
19. 19 Sciacca, FL, Ferri C, Vandenbroeck K, Veglia F, Gobbi C, Martinelli F, et al. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology 1999;10:1896-8.
20. 20 McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin 1 α polymorphism. Arthritis Rheum 1995;38:221-8.
21. 21 Bailly S, Hayem G, Fay M, Kahn MF, Gougerot-Pocidalo MA. Absence of correlation between IL-1 alpha intron 6 polymorphism and rheumatoid arthritis. Br J Rheumatol 1995;34:1123-4.
22. 22 Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, et al. Interleukin 1 β, interleukin 1 receptor antagonist, interleukin 4 and interleukin 10 gene polymorphisms. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-100.
23. 23 Santilla S, Savinainen K, Hume M. Presence of the IL-1 RA allele 2 (IL1RN*2) is associated with enhanced IL-1 beta production in vitro. Scand J Immunol 1998;47:195-8.
24. 24 Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180-6.
25. 25 Bowcock AM, Ray A, Erlich H, Sehgal PB. Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin 6 gene. Nucleic Acids Res 1989;17:6855-64.
26. 26 Olomolaiye O, Wood NAP, Bidwell JL. A NlaIII novel polymorphism in the human IL-6 promoter. Eur J Immunogenet 1998;25:267.
27. 27 Hajeer AH, Worthington J, Silman AJ, Ollier WER. Association of tumour necrosis factor microsatellite polymorphisms with HLA DR β1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996;39: 1109-14.
28. 28 Mu H, Chen JJ, Jiang Y, King MC, Thomson G, Criswell LA. Tumour necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA DR β1 shared epitope. Arthritis Rheum 1999;42:438-42.
29. 29 Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin 6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.